Detection and temporal monitoring of SARS-CoV-2 in Norwegian hospitals and other high transmission risk environments (NorCoV2)
- Funded by The Research Council of Norway (RCN)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$212,850Funder
The Research Council of Norway (RCN)Principal Investigator
Jostein GohliResearch Location
NorwayLead Research Institution
FORSVARETS FORSKNINGSINSTITUTTResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The extremely rapid spread of COVID-19 has resulted in a severe global impact. To stem the tide of the current pandemic, reducing transmission rates within populations and understanding the epidemiological dynamics of COVID-19 is of paramount importance. One way to reduce transmission is to reduce exposure, which requires knowledge about the exposure risk in different environments and scenarios. Further, identifying the sources of observed SARS-CoV-2 strains could identify important transmission routes. The NorCoV2 project will utilize environmental sampling in hospital, subway and airport environments, which are all important with regard to spreading infectious diseases. Air and surface samples will be collected weekly for a period of six months. The presence and abundance of SARS-CoV-2 will be analyzed with Real-Time Quantitative Reverse Transcription PCR (qRT-PCR), and samples where SARS-CoV-2 is detected will be direct RNA long-read sequenced on the Oxford Nanopore Technologies (ONT) MinION platform. The results from NorCoV2 will provide information on exposure risk in important infrastructures, examine the effectiveness of cleaning procedures and infection control measures, provide a high-resolution time series analysis of the current outbreak, and perform critical geographic tracking analyses of environmentally observed SARS-CoV-2 strains. Project members include important stakeholders from the hospital and mass transit sector, and the ENVIRION project, which will perform environmental monitoring of SARS-CoV-2 in sewage. The collaboration with ENVIRION will allow for cross-validation of these two separate monitoring approaches. NorCoV2 will also contribute to a large international SARS-CoV-2 mapping effort coordinated by the MetaSUB Consortium.